Join to view full profile
893 S Delaware StIndianapolis, IN 46226
Phone+1 317-695-4884
Dr. Moreira is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Katheryn Moreira is an Obstetrics and Gynecology specialist based in Indianapolis, IN. She completed her medical education and residency in Obstetrics and Gynecology at the University of Cincinnati, finishing in 2004, and earned an MBA from IU Kelley School of Business in 2015. She currently serves as an Executive Director in Medical Affairs at Eli Lilly Corporate Center, a position she has held since 2018, and previously practiced as a physician at Riverview Health from 2006 to 2018. She is a Fellow of the American Congress of Obstetricians and Gynecologists.
Education & Training
IU Kelley School of Business MBA, 2013 - 2015
University of Cincinnati Medical Center/College of MedicineResidency, Obstetrics and Gynecology, 2000 - 2004
University of Cincinnati College of MedicineClass of 2000
Certifications & Licensure
IN State Medical License 2006 - 2027
OH State Medical License 2000 - 2006
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification RelayClinical™ Solutions, McKesson, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2014-2017
- CMS Meaningful Use Stage 2 Certification Allscripts Professional EHR, Allscripts, 2014-2017
Publications & Presentations
PubMed
- Abemaciclib in HR+, HER2- Breast Cancer: A Narrative Review of the Clinical Evidence.Miguel Martin, Alexandru Rosca, Alexandra Searles Vitko, Monique Coersmeyer, Katheryn Moreira
Oncology and Therapy. 2026-06-15 - Abemaciclib Persistence in Patients with HR+, HER2-, Node-Positive Early Breast Cancer: a Real-World Analysis.Kathryn Hudson, Wambui Gathirua-Mwangi, Lindsay A Williams, Zhanglin Lin Cui, Madeline Richey
Oncology and Therapy. 2025-12-01
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
